Free Trial
CVE:LXG

LexaGene (LXG) Stock Price, News & Analysis

LexaGene logo
C$0.10 -0.03 (-19.23%)
As of 02/21/2023

About LexaGene Stock (CVE:LXG)

Key Stats

Today's Range
C$0.10
C$0.14
50-Day Range
C$0.11
C$0.11
52-Week Range
C$0.07
C$0.31
Volume
2.14 million shs
Average Volume
170,061 shs
Market Capitalization
C$14.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

LXG Stock News Headlines

Pamapol Ord Share Price (0LXG)
Biosynex SA ALBIO
I was wrong about Trump
Addiction. Crime. Corruption. One devastating lie may be fueling it all. A new exposé reveals the hidden cause behind America’s social unraveling—and why it could soon trigger a nationwide crisis. The same lie even reached the White House… and the promised reckoning never came.
Cyclopharm Ltd CYC
Lexagene Holdings Inc (LXGh)
Zhejiang Gongdong Medical Technology Co Ltd Class A
IIROC Trading Halt - LXG
See More Headlines

LXG Stock Analysis - Frequently Asked Questions

LexaGene's stock was trading at C$0.11 at the start of the year. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11.

Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT), Inovio Pharmaceuticals (INO) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
CVE:LXG
CIK
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$8.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-339.54%
Return on Assets
-120.21%

Debt

Debt-to-Equity Ratio
138.01
Current Ratio
1.39
Quick Ratio
1.13

Sales & Book Value

Annual Sales
C$110.93 thousand
Price / Sales
133.13
Cash Flow
C$0.00 per share
Price / Cash Flow
21.25
Book Value
C$0.01 per share
Price / Book
10.50

Miscellaneous

Outstanding Shares
140,640,000
Free Float
N/A
Market Cap
C$14.77 million
Optionable
Not Optionable
Beta
2.26
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:LXG) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners